ID   PTN_RAT                 Reviewed;         168 AA.
AC   P63090; P20935;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 1.
DT   29-MAY-2024, entry version 137.
DE   RecName: Full=Pleiotrophin {ECO:0000303|PubMed:2270483};
DE            Short=PTN {ECO:0000303|PubMed:2270483};
DE   AltName: Full=Heparin-binding brain mitogen {ECO:0000303|PubMed:2388713};
DE            Short=HBBM {ECO:0000303|PubMed:2388713};
DE   AltName: Full=Heparin-binding growth factor 8 {ECO:0000250|UniProtKB:P21782};
DE            Short=HBGF-8 {ECO:0000250|UniProtKB:P21782};
DE   AltName: Full=Heparin-binding growth-associated molecule {ECO:0000303|PubMed:2170351};
DE            Short=HB-GAM {ECO:0000303|PubMed:2170351};
DE   AltName: Full=Heparin-binding neutrophic factor {ECO:0000303|PubMed:1700712};
DE            Short=HBNF {ECO:0000303|PubMed:1700712};
DE   AltName: Full=Osteoblast-specific factor 1 {ECO:0000250|UniProtKB:P21246};
DE            Short=OSF-1 {ECO:0000250|UniProtKB:P21246};
DE   Flags: Precursor;
GN   Name=Ptn {ECO:0000312|RGD:3444};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=2170351; DOI=10.1016/s0021-9258(17)44817-4;
RA   Merenmies J., Rauvala H.;
RT   "Molecular cloning of the 18-kDa growth-associated protein of developing
RT   brain.";
RL   J. Biol. Chem. 265:16721-16724(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2270483; DOI=10.1126/science.2270483;
RA   Li Y.-S., Milner P.G., Chauhan A.K., Watson M.A., Hoffman R.M.,
RA   Kodner C.M., Milbrandt J., Deuel T.F.;
RT   "Cloning and expression of a developmentally regulated protein that induces
RT   mitogenic and neurite outgrowth activity.";
RL   Science 250:1690-1694(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 33-54.
RC   TISSUE=Brain;
RX   PubMed=2388713; DOI=10.1007/bf00969930;
RA   Huber D., Gautschi-Sova P., Bohlen P.;
RT   "Amino-terminal sequences of a novel heparin-binding protein from human,
RT   bovine, rat, and chick brain: high interspecies homology.";
RL   Neurochem. Res. 15:435-439(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 46-134.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=1700712; DOI=10.1016/0006-291x(90)90753-a;
RA   Kovesdi I., Fairhurst J.L., Kretschmer P.J., Boehlen P.;
RT   "Heparin-binding neurotrophic factor (HBNF) and MK, members of a new family
RT   of homologous, developmentally regulated proteins.";
RL   Biochem. Biophys. Res. Commun. 172:850-854(1990).
RN   [6]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=1768439; DOI=10.3109/08977199109000275;
RA   Kretschmer P.J., Fairhurst J.L., Decker M.M., Chan C.P., Gluzman Y.,
RA   Boehlen P., Kovesdi I.;
RT   "Cloning, characterization and developmental regulation of two members of a
RT   novel human gene family of neurite outgrowth-promoting proteins.";
RL   Growth Factors 5:99-114(1991).
RN   [7]
RP   INTERACTION WITH SDC3.
RX   PubMed=8175719; DOI=10.1016/s0021-9258(18)99975-8;
RA   Raulo E., Chernousov M.A., Carey D.J., Nolo R., Rauvala H.;
RT   "Isolation of a neuronal cell surface receptor of heparin binding growth-
RT   associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3).";
RL   J. Biol. Chem. 269:12999-13004(1994).
RN   [8]
RP   DEVELOPMENTAL STAGE, TISSUE SPECIFICITY, FUNCTION, AND INTERACTION WITH
RP   SDC3.
RX   PubMed=9817766; DOI=10.1083/jcb.143.4.1113;
RA   Imai S., Kaksonen M., Raulo E., Kinnunen T., Fages C., Meng X., Lakso M.,
RA   Rauvala H.;
RT   "Osteoblast recruitment and bone formation enhanced by cell matrix-
RT   associated heparin-binding growth-associated molecule (HB-GAM).";
RL   J. Cell Biol. 143:1113-1128(1998).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH PTPRZ1.
RX   PubMed=16814777; DOI=10.1016/j.febslet.2006.06.041;
RA   Fukada M., Fujikawa A., Chow J.P., Ikematsu S., Sakuma S., Noda M.;
RT   "Protein tyrosine phosphatase receptor type Z is inactivated by ligand-
RT   induced oligomerization.";
RL   FEBS Lett. 580:4051-4056(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH GPC2.
RX   PubMed=27671118; DOI=10.1038/srep33916;
RA   Paveliev M., Fenrich K.K., Kislin M., Kuja-Panula J., Kulesskiy E.,
RA   Varjosalo M., Kajander T., Mugantseva E., Ahonen-Bishopp A., Khiroug L.,
RA   Kulesskaya N., Rougon G., Rauvala H.;
RT   "HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the
RT   CNS extracellular matrix.";
RL   Sci. Rep. 6:33916-33916(2016).
CC   -!- FUNCTION: Secreted growth factor that mediates its signal through cell-
CC       surface proteoglycan and non-proteoglycan receptors (PubMed:16814777,
CC       PubMed:27671118, PubMed:9817766). Binds cell-surface proteoglycan
CC       receptor via their chondroitin sulfate (CS) groups (By similarity).
CC       Thereby regulates many processes like cell proliferation, cell
CC       survival, cell growth, cell differentiation and cell migration in
CC       several tissues namely neuron and bone (PubMed:27671118,
CC       PubMed:9817766). Also plays a role in synaptic plasticity and learning-
CC       related behavior by inhibiting long-term synaptic potentiation (By
CC       similarity). Binds PTPRZ1, leading to neutralization of the negative
CC       charges of the CS chains of PTPRZ1, inducing PTPRZ1 clustering, thereby
CC       causing the dimerization and inactivation of its phosphatase activity
CC       leading to increased tyrosine phosphorylation of each of the PTPRZ1
CC       substrates like ALK or AFAP1L2 in order to activate the PI3K-AKT
CC       pathway (PubMed:16814777). Through PTPRZ1 binding, regulates
CC       endothelial cell migration and controls oligodendrocyte precursor cell
CC       differentiation (By similarity). Forms a complex with PTPRZ1 and
CC       integrin alpha-V/beta-3 (ITGAV:ITGB3) that stimulates endothelial cell
CC       migration through SRC dephosphorylation and activation that
CC       consequently leads to ITGB3 'Tyr-773' phosphorylation (By similarity).
CC       In adult hippocampus promotes dendritic arborization, spine
CC       development, and functional integration and connectivity of newborn
CC       granule neurons through ALK by activating AKT signaling pathway (By
CC       similarity). Binds GPC2 and chondroitin sulfate proteoglycans (CSPGs)
CC       at the neuron surface, leading to abrogation of binding between PTPRS
CC       and CSPGs and neurite outgrowth promotion (PubMed:27671118). Binds SDC3
CC       and mediates bone formation by recruiting and attaching
CC       osteoblasts/osteoblast precursors to the sites for new bone deposition
CC       (PubMed:9817766). Binds ALK and promotes cell survival and cell
CC       proliferation through MAPK pathway activation (By similarity). Inhibits
CC       proliferation and enhances differentiation of neural stem cells by
CC       inhibiting FGF2-induced fibroblast growth factor receptor signaling
CC       pathway (By similarity). Mediates regulatory mechanisms in normal
CC       hemostasis and in hematopoietic regeneration and in maintaining the
CC       balance of myeloid and lymphoid regeneration (By similarity). In
CC       addition may play a role in the female reproductive system, auditory
CC       response and the progesterone-induced decidualization pathway (By
CC       similarity). {ECO:0000250|UniProtKB:P21246,
CC       ECO:0000250|UniProtKB:P63089, ECO:0000269|PubMed:16814777,
CC       ECO:0000269|PubMed:27671118, ECO:0000269|PubMed:9817766}.
CC   -!- SUBUNIT: Interacts with ALK and NEK6 (By similarity). Interacts with
CC       PTPRZ1 (via chondroitin sulfate groups); promotes formation of
CC       homooligomers; oligomerization impairs tyrosine phosphatase activity
CC       (PubMed:16814777). Forms a complex with PTPRZ1 and CTNNB1; this complex
CC       inactivates PTPRZ1 protein tyrosine phosphatase activity through PTN
CC       interaction and stimulates tyrosine phosphorylation of CTNNB1.
CC       Interacts with ITGB3 and ITGA5. Forms a complex with PTPRZ1 and
CC       integrin alpha-V/beta-3 (ITGAV:ITGB3) that stimulates endothelial cell
CC       migration through ITGB3 'Tyr-773' phosphorylation (By similarity).
CC       Interacts with SDC3 (via heparan sulfate chains); this interaction
CC       mediates the neurite outgrowth-promoting signal from PTN to the
CC       cytoskeleton of growing neurites; this interaction mediates osteoblast
CC       recruitment (PubMed:8175719, PubMed:9817766). Interacts with GPC2 (via
CC       heparan sulfate); this interaction promotes neurite outgrowth through
CC       binding of PTN with chondroitin sulfate of proteoglycans, thereby
CC       releasing PTPRS of chondroitin sulfate proteoglycans (CSPGs) and
CC       leading to binding with heparan sulfate of GPC2 (PubMed:27671118).
CC       {ECO:0000250|UniProtKB:P21246, ECO:0000269|PubMed:16814777,
CC       ECO:0000269|PubMed:27671118, ECO:0000269|PubMed:8175719,
CC       ECO:0000269|PubMed:9817766}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P21246}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain (PubMed:2170351). Hardly
CC       expressed in bone. Abundantly expressed in the growth plate. Intensely
CC       expressed in the cartilage matrix that forms the hollow for the
CC       secondary ossification center. Is expressed selectively by the
CC       osteocytes of the lamellar bone, whereas it is hardly expressed by
CC       those of the woven bone. Is detected in the matrix surrounding the
CC       osteocytes and in the canaliculi of the osteocytes. Is distributed on
CC       the surface of lamellar bone (PubMed:9817766).
CC       {ECO:0000269|PubMed:2170351, ECO:0000269|PubMed:9817766}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at low levels in the brain in early
CC       embryonic stages. Levels increase to a maximum before or just after
CC       birth, and are lower in adult brain (PubMed:1768439). At 16 dpc
CC       intensely expressed in the matrix of the developing cartilage and
CC       persists in the matrix of the mineralized cartilage at 20 dpc (at
CC       protein level). Localized within the unmineralized cartilage matrix (at
CC       mRNA level) (PubMed:9817766). {ECO:0000269|PubMed:1768439,
CC       ECO:0000269|PubMed:9817766}.
CC   -!- PTM: Phosphorylated by NEK6. {ECO:0000250|UniProtKB:P21246}.
CC   -!- SIMILARITY: Belongs to the pleiotrophin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M55601; AAA41310.1; -; mRNA.
DR   EMBL; M68916; AAA41311.1; -; mRNA.
DR   EMBL; BC062013; AAH62013.1; -; mRNA.
DR   PIR; B37780; B37780.
DR   RefSeq; NP_058762.1; NM_017066.2.
DR   AlphaFoldDB; P63090; -.
DR   SMR; P63090; -.
DR   BioGRID; 247030; 2.
DR   STRING; 10116.ENSRNOP00000016088; -.
DR   PhosphoSitePlus; P63090; -.
DR   PaxDb; 10116-ENSRNOP00000016088; -.
DR   Ensembl; ENSRNOT00000016088.7; ENSRNOP00000016088.4; ENSRNOG00000011946.8.
DR   Ensembl; ENSRNOT00055051649; ENSRNOP00055042590; ENSRNOG00055029802.
DR   Ensembl; ENSRNOT00060042263; ENSRNOP00060035045; ENSRNOG00060024368.
DR   Ensembl; ENSRNOT00065027733; ENSRNOP00065021854; ENSRNOG00065016642.
DR   GeneID; 24924; -.
DR   KEGG; rno:24924; -.
DR   UCSC; RGD:3444; rat.
DR   AGR; RGD:3444; -.
DR   CTD; 5764; -.
DR   RGD; 3444; Ptn.
DR   eggNOG; ENOG502RXV7; Eukaryota.
DR   GeneTree; ENSGT00390000007640; -.
DR   HOGENOM; CLU_136864_1_0_1; -.
DR   InParanoid; P63090; -.
DR   OrthoDB; 4608966at2759; -.
DR   PhylomeDB; P63090; -.
DR   TreeFam; TF332376; -.
DR   Reactome; R-RNO-201556; Signaling by ALK.
DR   Reactome; R-RNO-9851151; MDK and PTN in ALK signaling.
DR   PRO; PR:P63090; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000011946; Expressed in cerebellum and 20 other cell types or tissues.
DR   GO; GO:0005604; C:basement membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005576; C:extracellular region; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IEA:GOC.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0030246; F:carbohydrate binding; ISO:RGD.
DR   GO; GO:0035374; F:chondroitin sulfate binding; ISO:RGD.
DR   GO; GO:0035373; F:chondroitin sulfate proteoglycan binding; IPI:RGD.
DR   GO; GO:0005539; F:glycosaminoglycan binding; IDA:RGD.
DR   GO; GO:0008083; F:growth factor activity; IDA:RGD.
DR   GO; GO:1904399; F:heparan sulfate binding; IPI:RGD.
DR   GO; GO:0008201; F:heparin binding; IDA:RGD.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0140677; F:molecular function activator activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004864; F:protein phosphatase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0043394; F:proteoglycan binding; IPI:UniProtKB.
DR   GO; GO:0045545; F:syndecan binding; IPI:UniProtKB.
DR   GO; GO:0038085; F:vascular endothelial growth factor binding; IPI:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0034644; P:cellular response to UV; IEP:RGD.
DR   GO; GO:0071305; P:cellular response to vitamin D; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0046697; P:decidualization; ISS:UniProtKB.
DR   GO; GO:0140059; P:dendrite arborization; ISS:UniProtKB.
DR   GO; GO:0031104; P:dendrite regeneration; IDA:UniProtKB.
DR   GO; GO:0045446; P:endothelial cell differentiation; IEP:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0007507; P:heart development; IEP:RGD.
DR   GO; GO:0030902; P:hindbrain development; IEP:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007612; P:learning; IEP:RGD.
DR   GO; GO:0002232; P:leukocyte chemotaxis involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IEP:RGD.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0007613; P:memory; ISS:UniProtKB.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IDA:RGD.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; IMP:RGD.
DR   GO; GO:1900272; P:negative regulation of long-term synaptic potentiation; ISS:UniProtKB.
DR   GO; GO:0045837; P:negative regulation of membrane potential; IDA:RGD.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IDA:RGD.
DR   GO; GO:0007406; P:negative regulation of neuroblast proliferation; ISS:UniProtKB.
DR   GO; GO:1904397; P:negative regulation of neuromuscular junction development; IDA:RGD.
DR   GO; GO:0048477; P:oogenesis; ISS:UniProtKB.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0043932; P:ossification involved in bone remodeling; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0048680; P:positive regulation of axon regeneration; IDA:UniProtKB.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; ISS:UniProtKB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010811; P:positive regulation of cell-substrate adhesion; IDA:RGD.
DR   GO; GO:1900006; P:positive regulation of dendrite development; ISS:UniProtKB.
DR   GO; GO:2000347; P:positive regulation of hepatocyte proliferation; IDA:RGD.
DR   GO; GO:0002690; P:positive regulation of leukocyte chemotaxis; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:UniProtKB.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0045778; P:positive regulation of ossification; IMP:UniProtKB.
DR   GO; GO:1904395; P:positive regulation of skeletal muscle acetylcholine-gated channel clustering; IDA:RGD.
DR   GO; GO:2000738; P:positive regulation of stem cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043113; P:receptor clustering; ISS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:RGD.
DR   GO; GO:0010594; P:regulation of endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:1903706; P:regulation of hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0031641; P:regulation of myelination; ISS:UniProtKB.
DR   GO; GO:2000036; P:regulation of stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISS:UniProtKB.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0010996; P:response to auditory stimulus; ISS:UniProtKB.
DR   GO; GO:1904391; P:response to ciliary neurotrophic factor; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:1904373; P:response to kainic acid; IEP:RGD.
DR   GO; GO:1990089; P:response to nerve growth factor; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEP:RGD.
DR   GO; GO:0060221; P:retinal rod cell differentiation; IMP:RGD.
DR   GO; GO:1904389; P:rod bipolar cell differentiation; IEP:RGD.
DR   GO; GO:0021510; P:spinal cord development; IEP:RGD.
DR   GO; GO:0021794; P:thalamus development; IEP:RGD.
DR   GO; GO:0042246; P:tissue regeneration; ISS:UniProtKB.
DR   Gene3D; 2.20.60.10; Pleiotrophin/Midkine, N-terminal domain; 1.
DR   InterPro; IPR000762; Midkine_heparin-bd_GF.
DR   InterPro; IPR020090; PTN/MK_C_dom.
DR   InterPro; IPR038130; PTN/MK_C_dom_sf.
DR   InterPro; IPR020091; PTN/MK_diS_sf.
DR   InterPro; IPR020089; PTN/MK_N_dom.
DR   InterPro; IPR037122; PTN/MK_N_dom_sf.
DR   InterPro; IPR020092; PTN_MK_heparin-bd_GF_CS.
DR   PANTHER; PTHR13850:SF1; PLEIOTROPHIN; 1.
DR   PANTHER; PTHR13850; PLEIOTROPHIN FAMILY MEMBER; 1.
DR   Pfam; PF01091; PTN_MK_C; 1.
DR   Pfam; PF05196; PTN_MK_N; 1.
DR   PRINTS; PR00269; PTNMIDKINE.
DR   SMART; SM00193; PTN; 1.
DR   SUPFAM; SSF57288; Midkine; 2.
DR   PROSITE; PS00619; PTN_MK_1; 1.
DR   PROSITE; PS00620; PTN_MK_2; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Growth factor; Heparin-binding;
KW   Mitogen; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000269|PubMed:2388713"
FT   CHAIN           33..168
FT                   /note="Pleiotrophin"
FT                   /id="PRO_0000024661"
FT   REGION          92..99
FT                   /note="Chondroitin sulfate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
FT   REGION          123..131
FT                   /note="Chondroitin sulfate binding"
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
FT   REGION          139..168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          147..168
FT                   /note="Chondroitin sulfate A binding"
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
FT   COMPBIAS        148..168
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        47..76
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
FT   DISULFID        55..85
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
FT   DISULFID        62..89
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
FT   DISULFID        99..131
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
FT   DISULFID        109..141
FT                   /evidence="ECO:0000250|UniProtKB:P21246"
SQ   SEQUENCE   168 AA;  18869 MW;  2127DA167D2DD33D CRC64;
     MSSQQYQQQR RKFAAAFLAL IFILAAVDTA EAGKKEKPEK KVKKSDCGEW QWSVCVPTSG
     DCGLGTREGT RTGAECKQTM KTQRCKIPCN WKKQFGAECK YQFQAWGECD LNTALKTRTG
     SLKRALHNAD CQKTVTISKP CGKLTKPKPQ AESKKKKKEG KKQEKMLD
//
